Tanwei Gu

Guangdong Provincial Key Laboratory Of New Drug Screening
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Discovery of a novel anti-ischemic acute kidney injury candidate from pestaphilones, a new subtype of azaphilones derived from marine fungus.

Discovery of a novel anti-ischemic acute kidney injury candidate from pestaphilones, a new subtype of azaphilones derived from marine fungus.

Journal: European journal of medicinal chemistry

Published: June 27, 2026

Discovery of an Indole-Quinazoline Alkaloid as an Anti-kidney Fibrotic Agent from the Marine-Derived Aspergillus clavatonanicus SCSIO 41444.

Discovery of an Indole-Quinazoline Alkaloid as an Anti-kidney Fibrotic Agent from the Marine-Derived Aspergillus clavatonanicus SCSIO 41444.

Journal: Journal of natural products

Published: February 19, 2026

Temporal changes of hepatic drug-metabolizing enzymes mediated by hepatic ischemia-reperfusion injury and the protective effect of Oridonin.

Temporal changes of hepatic drug-metabolizing enzymes mediated by hepatic ischemia-reperfusion injury and the protective effect of Oridonin.

Journal: Scientific reports

Published: March 07, 2025

New Sesquiterpenoids from the Mangrove-Derived Fungus Talaromyces sp. as Modulators of Nuclear Receptors.

New Sesquiterpenoids from the Mangrove-Derived Fungus Talaromyces sp. as Modulators of Nuclear Receptors.

Journal: Marine drugs

Published: July 29, 2024

Discovery of Anti-Hypercholesterolemia Agents Targeting LXRα from Marine Microorganism-Derived Natural Products.

Discovery of Anti-Hypercholesterolemia Agents Targeting LXRα from Marine Microorganism-Derived Natural Products.

Journal: Journal of natural products

Published: February 09, 2024

A novel marine-derived anti-acute kidney injury agent targeting peroxiredoxin 1 and its nanodelivery strategy based on ADME optimization.

A novel marine-derived anti-acute kidney injury agent targeting peroxiredoxin 1 and its nanodelivery strategy based on ADME optimization.

Journal: Acta pharmaceutica Sinica. B

Published: November 17, 2023

Oridonin restores hepatic lipid homeostasis in an LXRα-ATGL/EPT1 axis-dependent manner.

Oridonin restores hepatic lipid homeostasis in an LXRα-ATGL/EPT1 axis-dependent manner.

Journal: Journal of pharmaceutical analysis

Published: March 01, 2023

Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis.

Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis.

Journal: Cell death & disease

Published: September 18, 2022

Lipid metabolism regulatory activity and adverse effects of fungi-derived butyrolactone I.

Lipid metabolism regulatory activity and adverse effects of fungi-derived butyrolactone I.

Journal: Natural product research

Published: September 12, 2022

Oridonin alleviates hyperbilirubinemia through activating LXRα-UGT1A1 axis.

Oridonin alleviates hyperbilirubinemia through activating LXRα-UGT1A1 axis.

Journal: Pharmacological research

Published: November 05, 2021

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.

Journal: Frontiers in pharmacology

Published: September 08, 2021

Effect of oridonin on oxylipins in the livers of mice with acute liver injury induced by D-galactosamine and lipopolysaccharide.

Effect of oridonin on oxylipins in the livers of mice with acute liver injury induced by D-galactosamine and lipopolysaccharide.

Journal: International immunopharmacology

Published: July 25, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026